Media

Media

filter by theme
WOMEN's HEALTH
ENDOCRINOLOGY
Cell therapy
CORPORATE
REGULATORY

October 2013

31

HRA Pharma and Laboratoires Carilene Sign an Exclusive Distribution Agreement for a Product Indicated in the Symptomatic Treatment of Genital Herpes

April 2013

25

HRA Pharma reçoit la visite de Mme. Najat Vallaud Belkacem, Ministre des Droits des femmes, à son siège parisien

December 2012

03

HRA Pharma’s CEO, Erin Gainer, honored with La Tribune Women’s Award

November 2012

23

HRA Pharma announce adrenocortical carcinoma award winners at ENS@T 2012 meeting

September 2012

04

HRA Pharma to exceed €50 million turnover in 2012 as ellaOne made available in over 50 countries worldwide

June 2012

11

Richter and HRA Pharma Expand their Marketing Agreement for Esmya® to Latin America

Février 2012

27

Uliprisrtal Acetate Granted European Marketing Authorisation for the Treatment of Symptoms Of Uterine Fibroids

Février 2012

02

NEJM Features Two Positive Pivotal Trials of HRA Pharma Compound Ulipristal Acetate for the Treatment of Uterine Fibroids

filter by theme
WOMEN's HEALTH
ENDOCRINOLOGY
Cell therapy
CORPORATE
REGULATORY
closeyou are leaving hra pharma
You are now leaving www.hra-pharma.com and being redirected to an external website which might not be under control of HRA Pharma.
do you want to proceed ?